Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar

New Microbes and New Infections

Volumn 11, Issue , 2016, Pages 47-51

  Rolain, J M ^a   Loucif, L ^a,c   Al Maslamani, M ^b   Elmagboul, E ^b   Al Ansari, N ^b   Taj Aldeen, S ^b   Shaukat, A ^b   Ahmedullah, H ^b   Hamed, M ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c UNIVERSITY OF BATNA   (Algeria)

Author keywords

Acinetobacter baumannii; Carbapenemase blaOXA 23; Clonality analysis; Multidrug resistant bacteria; Qatar

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEMASE; CARBAPENEMASE OXA23; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QATAR; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84961123541     PISSN: 20522975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmni.2016.02.006     Document Type: Article

References (28)

1. Manual of clinical microbiology 2011, ASM Press, Washington, DC. 10th ed. J. Versalovic, K.C. Carroll, G. Funke, J.H. Jorgensen, M.L. Landry, D.W. Warnock (Eds.).
2. Nemec A., De B.T., Tjernberg I., Vaneechoutte M., van der Reijden T.J., Dijkshoorn L. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 2001, 51(Pt 5):1891-1899.
3. Sevillano E., Gallego L. Molecular techniques for detection and control of nosocomial infections caused by Acinetobacter baumannii. Science against microbial pathogens: communicating current research and technological advances 2011, 495-503. Formatex Research Center, Badajoz, Spain. http://www.formatex.info/microbiology3/book/495-503.pdf, A. Mendez-Vilas (Ed.).
4. Allen D.M., Hartman B.J. Acinetobacter species. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 2009, 2881-2885. Churchill Livingstone Elsevier, New York. 7th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
5. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
6. Fournier P.E., Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006, 42:692-699.
7. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
8. Zowawi H.M., Sartor A.L., Sidjabat H.E., Balkhy H.H., Walsh T.R., Al Johani S.M., et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers. J Clin Microbiol 2015, 53:896-903.
9. Seng P., Rolain J.M., Fournier P.E., La S.B., Drancourt M., Raoult D. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 2010, 5:1733-1754.
10. Bakour S., Touati A., Sahli F., Ameur A.A., Haouchine D., Rolain J.M. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria. Diagn Microbiol Infect Dis 2013, 76:529-531.
11. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013, 30:2725-2729.
12. Kempf M., Rolain J.M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 2012, 39:105-114.
13. Biswas S., Brunel J.M., Dubus J.C., Reynaud-Gaubert M., Rolain J.M. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 2012, 10:917-934.
14. Kempf M., Rolain J.M., Azza S., Diene S., Joly-Guillou M.L., Dubourg G., et al. Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation. APMIS 2013, 121:64-71.
15. Sonnevend A., Al B.A., Ghazawi A., Hashmey R., Girgis S., Hamadeh M.B., et al. Emergence and spread of NDM-1 producer Enterobacteriaceae with contribution of IncX3 plasmids in the United Arab Emirates. J Med Microbiol 2013, 62(Pt 7):1044-1050.
16. Dortet L., Poirel L., Al Y.F., Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012, 18:E144-E148.
17. Shibl A., Al-Agamy M., Memish Z., Senok A., Khader S.A., Assiri A. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis 2013, 17:e1130-e1133.
18. Al-Sweih N.A., Al-Hubail M., Rotimi V.O. Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J Infect Public Health 2012, 5:102-108.
19. Al-Hassan L., El Mehallawy H., Amyes S.G. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect 2013, 19:1082-1088.
20. Al-Arfaj A.A., Ibrahim A.S.S., Al-Salamah A.A. Genetic basis of carbapenem resistance in Acinetobacter clinical isolates in Saudi Arabia. Afr J Biotechnol 2011, 10:14186-14196.
21. Abdalhamid B., Hassan H., Itbaileh A., Shorman M. Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiol 2014, 37:65-73.
22. Opazo A., Sonnevend A., Lopes B., Hamouda A., Ghazawi A., Pal T., et al. Plasmid-encoded PER-7 beta-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates. J Antimicrob Chemother 2012, 67:1619-1622.
23. Mugnier P., Poirel L., Pitout M., Nordmann P. Carbapenem-resistant and OXA-23 producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin Microbiol Infect 2008, 14:879-882.
24. Mugnier P.D., Bindayna K.M., Poirel L., Nordmann P. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain. J Antimicrob Chemother 2009, 63:1071-1073.
25. Bakour S., Alsharapy S.A., Touati A., Rolain J.M. Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen. Microb Drug Resist 2014, 20:604-609.
26. El Shafie S., Mohsin Z., Mohsin T., Al Soub H. Antibiotic resistance pattern among aerobic Gram negative bacilli isolated from patients in intensive care units. Qatar Med J 2005, 14:129-133.
27. Khan F.Y., Elshafie S.S., Almaslamani M., Abu-Khattab M., El Hiday A.H., Errayes M., et al. Epidemiology of bacteraemia in Hamad General Hospital, Qatar: a one year hospital-based study. Travel Med Infect Dis 2010, 8:377-387.
28. El Shafie S.S., Alishaq M., Leni G.M. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect 2004, 56:101-105.